5418 - Thromboembolism: Drugs (Answered)

Luciana Berger
To ask the Secretary of State for Health, what the reasons are for the time taken to publish the Medicines and Healthcare products Regulatory Agency review into the safety of alteplase; and when this review will be published.

George Freeman

An Expert Working Group of the Commission on Human Medicines (CHM) has been established to conduct a comprehensive review of the available evidence on the use of alteplase in stroke in the United Kingdom. Evidence has been gathered from a wide range of sources and carefully evaluated. The Group’s conclusions and recommendations remain confidential while the review is ongoing and will be published after their consideration by the CHM.